Dermatomyofibroma on the nape of the neck: a report of 2 pediatric cases.

3. Thirion L, Nikkels AF, Piérard GE. Etoricoxib-induced erythemamultiforme-like eruption. Dermatology. 2008;216:227--8. 4. Kreft B, Wohlrab J, Bramsiepe I, Eismann R, Winkler M, Marsch WC. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol. 2010;37:904--6. 5. Augustine M, Sharma P, Stephen J, Jayaseelan E. Fixed drug eruption and generalised erythema following etoricoxib. Indian J Dermatol Venereol Leprol. 2006;72:307--9. 6. Duarte AF, Correia O, Azevedo R, Palmares MD, Delgado L. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement. Eur J Dermatol. 2010;20:236--8. 7. Calistru AM, Cunha AP, Nogueira A, Azevedo F. Etoricoxibinduced fixed drug eruption with positive lesional patch tests. Cutan Ocul Toxicol. 2011;30:154. 8. Andrade P, Gonçalo M. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing. Contact Dermatitis. 2011;64:110--20. 9. Ponce V, Muñoz-Bellido F, Moreno E, Laffond E, González A, Dávila I. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib. Contact Dermatitis. 2012;66:106--12. 10. Andrade P, Brinca A, Gonçalo M. Patch testing in fixed drug eruptions----a 20-year review. Contact Dermatitis. 2011;65: 195--201. 11. Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, PougetJasson C, Amarger S, et al. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol. 2010;20:461--4.